Arcadia Biosciences Retained Earnings (Accumulated Deficit) 2014-2024 | RKDA
Arcadia Biosciences retained earnings (accumulated deficit) from 2014 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Arcadia Biosciences Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2023 |
$-272 |
| 2022 |
$-258 |
| 2021 |
$-226 |
| 2020 |
$-212 |
| 2019 |
$-207 |
| 2018 |
$-178 |
| 2017 |
$-167 |
| 2016 |
$-152 |
| 2015 |
$-132 |
| 2014 |
$-114 |
| 2013 |
$-96 |
Arcadia Biosciences Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024-06-30 |
$-273 |
| 2024-03-31 |
$-274 |
| 2023-12-31 |
$-272 |
| 2023-09-30 |
$-269 |
| 2023-06-30 |
$-266 |
| 2023-03-31 |
$-267 |
| 2022-12-31 |
$-258 |
| 2022-09-30 |
$-254 |
| 2022-06-30 |
$-251 |
| 2022-03-31 |
$-247 |
| 2021-12-31 |
$-226 |
| 2021-09-30 |
$-217 |
| 2021-06-30 |
$-215 |
| 2021-03-31 |
$-210 |
| 2020-12-31 |
$-212 |
| 2020-09-30 |
$-221 |
| 2020-06-30 |
$-214 |
| 2020-03-31 |
$-205 |
| 2019-12-31 |
$-207 |
| 2019-09-30 |
$-201 |
| 2019-06-30 |
$-187 |
| 2019-03-31 |
$-191 |
| 2018-12-31 |
$-178 |
| 2018-09-30 |
$-178 |
| 2018-06-30 |
$-182 |
| 2018-03-31 |
$-176 |
| 2017-12-31 |
$-167 |
| 2017-09-30 |
$-164 |
| 2017-06-30 |
$-160 |
| 2017-03-31 |
$-156 |
| 2016-12-31 |
$-152 |
| 2016-09-30 |
$-146 |
| 2016-06-30 |
$-142 |
| 2016-03-31 |
$-137 |
| 2015-12-31 |
$-132 |
| 2015-09-30 |
$-128 |
| 2015-06-30 |
$-123 |
| 2015-03-31 |
$-120 |
| 2014-12-31 |
$-114 |
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
$-96 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Agricultural Products |
$0.006B |
$0.005B |
|
Arcadia Biosciences, Inc. is engaged in developing and commercializing agricultural products primarily in the United States. The Company's product includes nitrogen use crops, salt tolerant plants, sunflower oil and shelf-life produce. Arcadia Biosciences, Inc. is headquartered in Davis, California.
|
